In vitro evaluation of temozolomide combined with X-irradiation

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Anti-Cancer Drugs

• Publication date

  1997-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00001813-199701000-00013PMID 9147618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of murine O6-alkylguanine-DNA-alkyltransferase in response to ionising radiation is p53 gene dose dependent.

  1996cited by this paper
• Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.

  1996cited by this paper
• O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU.

  1996cited by this paper
• Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.

  1995cited by this paper
• In vivo induction of O6-alkylguanine-DNA-alkyltransferase in response to indium-114m.

  1994cited by this paper
• Analysis of the p53 gene and its expression in human glioblastoma cells.

  1994cited by this paper
• p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.

  1994cited by this paper
• Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours.

  1993cited by this paper
• Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

  1993cited by this paper
• O6-methylguanine residues elicit DNA repair synthesis by human cell extracts.

  1993cited by this paper
• O6-methylguanine in DNA inhibits replication in vitro by human cell extracts.

  1993cited by this paper
• Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells.

  1993cited by this paper
• Malignant glioma--timing of response to radiation therapy.

  1993cited by this paper
• Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain.

  1993cited by this paper
• A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

  1992cited by this paper
• Chinese hamster ovary cells deficient or proficient in O6-alkylguanine-DNA alkyltransferase activity are equally sensitive to X-rays.

  1992cited by this paper
• Chromosomal localization of human O6-methylguanine-DNA methyltransferase (MGMT) gene by in situ hybridization.

  1992cited by this paper
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

  1992cited by this paper
• Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).

  1992cited by this paper
• Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments

  1991cited by this paper
• The effects of X-irradiation, N-ethyl-N-nitrosourea or combined treatment on O6-alkylguanine-DNA alkyltransferase activity in fetal rat brain and liver and the induction of CNS tumours.

  1990cited by this paper
• Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.

  1990cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990cited by this paper
• DNA damage and repair following treatment with ionizing radiation.

  1990cited by this paper
• The search for therapeutic gain in the combination of radiotherapy and chemotherapy.

  1988cited by this paper
• Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

  1987cited by this paper
• O6-Methylguanine methyltransferase activity is increased in rat tissues by ionising radiation.

  1985cited by this paper
• Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity.

  1979cited by this paper

• Impact of IDH mutation and MGMT methylation as Independent prognostic markers in uniformly treated high grade glioma Patients: A Real-World evidence in the Indian Population.

  2026cites this paper
• ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines

  2023cites this paper
• Computational modelling of perivascular-niche dynamics for the optimization of treatment schedules for glioblastoma

  2021cites this paper
• Adjuvant Temozolomide for the Treatment of Glioblastoma: A Meta-analysis of Randomized Controlled Studies

  2021cites this paper
• Comparative Study Between Whole Brain Radiotherapy And Concurrent Temozolomide Versus Whole Brain Radiotherapy Alone For Patients Of Brain Metastasis

  2021cites this paper
• Malignant optic nerve glioma in a young woman with 7 year follow up without recurrence

  2020cites this paper
• In vitro effect of ionizing radiation on primary glioblastoma cells as a basis for multitarget therapy

  2020cites this paper
• Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database

  2018cites this paper
• Temozolomide during radiotherapy of glioblastoma multiforme

  2017cites this paper
• Molecular signalling pathways in canine gliomas

  2017cites this paper
• Pseudoprogression as an adverse event of glioblastoma therapy

  2017cites this paper
• Chapter 9 – Chemotherapeutics and Their Efficacy

  2016cites this paper
• The correlation between osteopontin level and radiation response of malignant gliomas at Cipto Mangunkusumo Hospital

  2016cites this paper
• Success and Failures of Combined Modalities in Glioblastoma Multiforme: Old Problems and New Directions.

  2016cites this paper
• Treatment of recurrent metastatic uterine leiomyosarcoma of the spine: a multimodality approach using resection, radiosurgery, and chemotherapy.

  2015cites this paper
• A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients

  2015cites this paper
• Outcome of treatment with concurrent whole brain radiotherapy and Temozolomide in brain metastasis

  2015cites this paper
• PRACTICE GUIDELINE SERIES

  2015cites this paper
• Identification of compounds that target glioma initiating cells

  2015cites this paper
• Effects of Single or Combined Treatments with Radiation and Chemotherapy on Survival and Danger Signals Expression in Glioblastoma Cell Lines

  2014cites this paper
• INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study

  2014cites this paper
• Application progress of temozolomide in clinical tumor chemotherapy

  2013cites this paper
• Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study.

  2013cites this paper
• The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma

  2013cites this paper
• Temozolomide in combination with carbon ion or photon irradiation in glioblastoma multiforme cell lines – does scheduling matter?

  2013cites this paper
• Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution

  2013cites this paper
• Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review).

  2013cites this paper
• Radiation sensitivity and sensitization in melanoma

  2013cites this paper
• Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma

  2013cites this paper
• Health-related quality of life in rural children living in four European countries: the GABRIEL study

  2013cites this paper
• Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma

  2013cites this paper
• In Vitro Evaluation of Combined Temozolomide and Radiotherapy Using X Rays and High-Linear Energy Transfer Radiation for Glioblastoma

  2012cites this paper
• Status Quo—Standard-of-Care Medical and Radiation Therapy for Glioblastoma

  2012cites this paper
• The role of adjuvant radiation therapy in the management of high-grade gliomas.

  2012cites this paper
• TEMOZOLOMIDE IN MALIGNANT ASTROCYTIC GLIOMAS

  2012cites this paper
• Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma

  2012cites this paper
• Chemotherapy and target therapy in the management of adult high- grade gliomas.

  2012cites this paper
• Blocking the Notch Pathway with Gamma-Secretase Inhibitors Enhances Temozolomide Treatment of Gliomas through Therapy-Induced Senescence: A Dissertation

  2011cites this paper
• Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?

  2011cites this paper
• The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer?

  2011cites this paper
• Determination of the methylation status of MGMT in different regions within glioblastoma multiforme

  2011cites this paper
• Reirradiation and Concomitant Metronomic Temozolomide: An Efficient Combination for Local Control in Medulloblastoma Disease?

  2011cites this paper
• Brief Report: Phase II Multicenter Study of Temozolomide in Patients with Cisplatin-Resistant Germ Cell Tumors

  2011cites this paper
• Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells

  2011cites this paper
• Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.

  2011cites this paper
• Telomere Targeting with a New G4 Ligand Enhances Radiation-Induced Killing of Human Glioblastoma Cells

  2011cites this paper
• Therapeutic Discovery Telomere Targeting with a New G 4 Ligand Enhances Radiation-Induced Killing of Human Glioblastoma Cells

  2011cites this paper
• Evolvement of Molecular Biomarkers in Targeted Therapy of Malignant Gliomas

  2011cites this paper
• Temozolomide in malignant glioma

  2010cites this paper
• Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution

  2010cites this paper
• Current therapeutic paradigms in glioblastoma.

  2010cites this paper
• A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma.

  2010cites this paper
• Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study

  2010cites this paper
• Concomitant or adjuvant temozolomide with whole-brain irradiation for brain metastases: a meta-analysis

  2010cites this paper
• Combination of Intracranial Temozolomide With Intracranial Carmustine Improves Survival When Compared With Either Treatment Alone in a Rodent Glioma Model

  2010cites this paper
• Strategizing the clone wars: pharmacological control of cellular sensitivity to radiation.

  2010cites this paper
• A case of relapsed medulloblastoma treated with intensity-modulated radiotherapy and temozolomide.

  2010cites this paper
• A Case of Relapsed Medulloblastoma Treated with Intensity-Modulated Radiotherapy and Temozolomide

  2010cites this paper
• Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.

  2009cites this paper
• Insights into pharmacotherapy of malignant glioma in adults

  2009cites this paper
• The Neuropharmacokinetics of Temozolomide in Patients with Resectable Brain Tumors: Potential Implications for the Current Approach to Chemoradiation

  2009cites this paper
• Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent.

  2009cites this paper
• Molecular advances of brain tumors in radiation oncology.

  2009cites this paper
• Outcome of Newly Diagnosed Glioblastoma Patients Treated by Radiotherapy plus Concomitant and Adjuvant Temozolomide: A Long-Term Analysis

  2009cites this paper
• Temozolomide with Radiation Therapy in High Grade Brain Gliomas: Pharmaceuticals Considerations and Efficacy; A Review Article

  2009cites this paper
• Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression

  2009cites this paper
• Radiosensitizers in Neurooncology

  2009cites this paper
• 64 Radiosensitizers Neurooncology

  2009cites this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cites this paper
• Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: tumour progression or radionecrosis?

  2009cites this paper
• The combination topotecan, temozolomide and dexamethasone associated with radiotherapy as treatment of central nervous system myeloma relapse

  2009cites this paper
• [A Clinical Observation of Concomitant Therapy of Erlotinib and Whole Brain Radiotherapy in Patients of NSCLC Combined with Brain Metastases.].

  2009cites this paper
• Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas

  2009influential citation
• Radiotherapy and temozolomide in glioblastoma: Predictive factors of response to the treatment

  2008cites this paper
• Glioblastoma Multiforme : Multidisciplinary Care and Advances in Therapy

  2008cites this paper
• Overcoming therapeutic resistance in malignant gliomas: current practices and future directions.

  2008cites this paper
• Phase Ι trial of weekly Docetaxel and daily Temozolomide in patients with metastatic disease

  2008cites this paper
• In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide

  2008cites this paper
• Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens.

  2008cites this paper
• Mechanisms of Disease: temozolomide and glioblastoma—look to the future

  2008cites this paper
• In vitro and In vivo Radiosensitization Induced by the DNA Methylating AgentTemozolomide

  2008cites this paper
• In vitro and In vivo Radiosensitization Induced by the DNA Methylating

  2008cites this paper
• Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme.

  2008cites this paper
• Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach

  2008cites this paper
• Optimizing radiotherapy of brain tumours by a combination of temozolomide & lonidamine.

  2008cites this paper
• Concurrent Chemoradiotherapy for Malignant Glioma: Dead End or Highway?

  2008cites this paper
• Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine

  2008cites this paper
• Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents.

  2008cites this paper
• The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma

  2008cites this paper
• In-vitro-Untersuchungen zur Kombinationswirkung von

  2008cites this paper
• Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma.

  2008cites this paper
• Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines

  2008cites this paper
• The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation.

  2007cites this paper
• Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.

  2007influential citation
• Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.

  2007cites this paper
• Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life

  2007cites this paper
• Chemoradiotherapy in malignant glioma: standard of care and future directions.

  2007cites this paper
• Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma

  2007cites this paper
• Impact of molecular profiling on clinical trial design for glioblastoma

  2007cites this paper
• New chemotherapy options for the treatment of malignant gliomas

  2007cites this paper